Pharmacological Predictors of Morbidity and Mortality in COVID-19.

ABSTRACT: The interaction of coronavirus disease (COVID-19) with the majority of common prescriptions is broadly unknown. The purpose of this study is to identify medications associated with altered disease outcomes in COVID-19. A retrospective cohort composed of all adult inpatient admissions to our center with COVID-19 was analyzed. Data concerning all antecedent prescriptions were collected and agents brought forward for analysis if prescribed to at least 20 patients in our cohort. Forty-two medications and 22 classes of medication were examined. Groups were propensity score matched and analyzed by logistic and linear regression. The majority of medications did not show a statistically significant relationship with altered disease outcomes. Lower mortality was associated with use of pregabalin (h

SUBMITTER: Oddy C 

PROVIDER: S-EPMC8242508 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature